International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Brian T. Tsuji(University at Buffalo, State University of New York), Keith S. Kaye(Johnson University)
Cited by 909
Related Papers
Strategies to Prevent Surgical Site Infections in Acute Care Hospitals
|Infection Control and Hospital Epidemiology|2008|488
Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals
|Infection Control and Hospital Epidemiology|2008|462
Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute Care Hospitals
|Infection Control and Hospital Epidemiology|2008|381
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals
|Infection Control and Hospital Epidemiology|2008|344
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
|The Lancet Infectious Diseases|2020|328